Down 19.85% pre-market: Europlasma S.A. (1EZ0.F XETRA) top loser, valuation test

1EZ0.F stock leads pre-market losers after a -19.85% slide to EUR 0.09 on XETRA on 27 Jan 2026. Volume spiked to 12,650 shares, well above the average of 3,654, as sellers reacted to weak fundamentals and stretched historical pricing. Europlasma S.A. (1EZ0.F) now trades near its year low and faces intense scrutiny on liquidity, valuation, and near-term catalysts in Germany’s Industrials segment.

Price action and session context for 1EZ0.F stock

Europlasma S.A. (1EZ0.F) opened at EUR 0.10 and hit a day low of EUR 0.09 in pre-market trade on XETRA. The one-day change of -19.85% follows deeper losses over recent periods: 1M -61.30% and 3M -90.18%. Traders should note the relVolume 3.46 reading, signalling active repositioning ahead of the open.

This move sits against a large historical swing. The stock’s year high remains EUR 88.25, a figure reflecting past corporate events and share structure shifts rather than comparable operating scale today.

Fundamentals and valuation pressure on 1EZ0.F stock

Europlasma reports negative earnings metrics: EPS -88.61 and a trailing PE that is not meaningful. Key ratios show stress: current ratio 0.77, cash per share EUR 0.00 (rounded), and price-to-sales 0.01. Enterprise value to sales is 0.28, but free cash flow metrics are deeply negative, highlighting operating cash weakness.

Investors should weigh these numbers with shares outstanding of 1,842,116,000 and a market cap near EUR 162,843,054.00. The company operates in Waste Management technology within Industrials, where peers show stronger operating margins and higher return on equity.

Technical signals and short-term outlook for 1EZ0.F stock

Momentum and volatility indicators point to oversold conditions. RSI sits at 32.84 and CCI at -128.72, while ATR reads 0.05, signalling elevated percentage moves at the current price. Bollinger band width has tightened, but MACD is slightly negative with a histogram near zero.

Short-term support is near the day low EUR 0.09 with initial resistance at the 50-day average EUR 0.31. Given thin nominal pricing, expect wide intraday swings and limited stop precision.

Meyka AI grade, model forecasts and 1EZ0.F stock outlook

Meyka AI rates 1EZ0.F with a score out of 100: 63.08 / 100, Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These scores are informational and not advice.

Meyka AI’s forecast model projects a monthly figure of EUR -0.44, compared with the current price EUR 0.09, implying an unrealistic downside of -597.68%. Forecasts are model-based projections and not guarantees. Analysts often treat such negative monthly outputs as model artifacts for very low-priced equities; use them only as one input in risk assessment.

Risks, catalysts and sector context for 1EZ0.F stock

Primary risks include continued negative earnings, weak liquidity, and low operating cash flow. Europlasma’s negative margins and long days sales outstanding (143 days) raise working capital concerns. The Industrials sector has outperformed recently, with 6M sector performance near 7.49%, exposing Europlasma’s relative underperformance.

Potential catalysts include new commercial contracts for plasma waste solutions, asset sales, or clear restructuring guidance. Absent those, the stock remains vulnerable to further de-risking and volatility.

Trading considerations and realistic price targets for 1EZ0.F stock

At the current level traders may prefer short-term setups and strict risk controls. Given the balance sheet and cash-flow profile, buy-and-hold investors should demand clear operational improvements before adding exposure.

Reasonable near-term technical targets are EUR 0.05 support and EUR 0.20 resistance. A cautious 12-month price target for scenarios where operations stabilise is EUR 0.50, while a downside stress case could drive price below EUR 0.02. These targets are illustrative and contingent on corporate events and sector recovery.

Final Thoughts

Key takeaways: 1EZ0.F stock slid -19.85% pre-market to EUR 0.09, with volume at 12,650 shares. Fundamentals show negative EPS -88.61, weak current ratio 0.77, and stretched cash flow. Meyka AI rates 1EZ0.F with a score out of 100: 63.08, Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Short-term traders will see higher volatility and tight stops are advisable. Longer-term investors should wait for improving cash flow or clear strategic actions.

Meyka AI’s forecast model projects EUR -0.44 monthly, which implies -597.68% on paper versus today’s price; this indicates a model artefact rather than a literal target. Forecasts are model-based projections and not guarantees. For now, view Europlasma as a high-risk Industrials small-cap, monitor corporate updates on Europlasma’s site and our coverage on the Meyka stock page for live changes.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.